Bevacizumab dramatically improves severe hereditary hemorrhagic telangiectasia (HHT) associated…
Credit: Mayo Clinic Proceedings Rochester, MN, January 29, 2018 – Patients with hereditary hemorrhagic telangiectasia (HHT) with severe bleeding, who were treated with intravenous bevacizumab,...












